Nasal DNA Vaccine Targets Hidden TB Bacteria | Science News
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Nasal DNA Vaccine Targets Hidden TB Bacteria | Science News
-
Narrated by:
-
By:
Scientists at Johns Hopkins have developed a groundbreaking nasal DNA vaccine that targets hidden TB bacteria, slashing treatment time and boosting existing drugs against resistant strains. By training immune cells to attack “persister” cells directly in the lungs, this spray-like therapy cleared infections faster in animal trials and prevented relapses. Early results in mice and monkeys show lasting immunity and reduced inflammation, offering hope for a future where TB treatment is shorter, more effective, and accessible — especially as drug-resistant cases rise globally.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/78b4364ff11ab98c